Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1859 of 5804
-
Diet change may boost sperm health in IVF couples
Knowledge-focused Recruiting nowIn this study, patients with infertility treated with IVF at the Center of Reproductive Medicine in Linköping, Sweden, will receive recipes and food according to Nordic dietary guidelines. The purpose is to investigate whether a short diet intervention is sufficient to improve sp…
Phase: NA • Sponsor: Ostergotland County Council, Sweden • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New pill aims to lift depression in days, not weeks
Symptom relief OngoingThe purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Real-World data may reveal best Second-Line therapy for multiple myeloma
Knowledge-focused CompletedThis retrospective observational study will use data from the OneOncology United States database to evaluate clinical outcomes in adults with relapsed/refractory multiple myeloma who received pomalidomide-containing or non-pomalidomide-containing treatment as second-line or third…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New sedative may prevent Post-Surgery confusion in seniors
Symptom relief CompletedThere are many factors that make elderly patients prone to POD. On the basis of these factors, surgery and anesthesia can increase the incidence of POD in elderly patients. Deep depth of intraoperative anesthesia and persistent hypotension may increase the risk of POD occurrence …
Phase: PHASE4 • Sponsor: Wang Tianlong • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New hope for high potassium: phase 3 drug trial launches
Disease control Recruiting nowThis clinical trial consists of 2 parts, Part A and Part B. Part A consists of a 2-day randomized, double-blind, placebo-controlled corrective phase (CP) and a 28-day randomized, double-blind, placebo-controlled maintenance phase (MP). Part B (open-label extension, OLE) is an ope…
Phase: PHASE3 • Sponsor: Waterstone Pharmaceutical (Wuhan) Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Exercise program may boost quality of life and cut costs for breast cancer patients
Symptom relief Recruiting nowAdapted physical activity (APA) was recognized as a non-drug therapy by the French Health Authority (HAS) in 2011. Very few studies have examined the efficiency of APA programs during the active phase of treatment in cancer patients. The investigators assumed that non-drug therap…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Bathroom breakthrough: new wash may stop UTIs in older women
Prevention OngoingA two-arm randomized control trial evaluating rates of urinary tract infection in post-menopausal women on vaginal estrogen with recurrent urinary tract infections.
Phase: PHASE4 • Sponsor: Oregon Health and Science University • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
New recovery pathway aims to cut repeat surgeries for brain bleed in elderly
Disease control Recruiting nowA chronic subdural hematoma (cSDH) is a type of intracranial hematoma that primarily affects older adults. The rising incidence of this condition, coupled with the high healthcare burden of this disease, calls for an update of the medical care program. We introduced an enhanced r…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for scleroderma: arthritis drug tofacitinib tested against skin thickening
Disease control CompletedThis study aims to evaluate the efficacy of Tofacitinib compared to Methotrexate (MTX) in reducing skin thickening in patients with diffuse cutaneous systemic sclerosis (dcSSc). Systemic sclerosis is a chronic autoimmune disease characterized by skin fibrosis and internal organ i…
Phase: PHASE4 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New HPV vaccine aims to block more cancer types in early trial
⭐️ VACCINE ⭐️ OngoingResearchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. There are many different types of HPV. Most people's immune system can fight HPV infection and it goes away without treatment. For som…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
New gel could treat painful skin vein bumps
Disease control OngoingA Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX022 (sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
Phase: PHASE2 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New tool aims to slash months-long thyroid dose adjustment to weeks
Symptom relief Recruiting nowLevothyroxine is the most used thyroid hormone replacement when the thyroid gland is failing. Because dosage adjustment normally takes several months, the investigators have developed a decision support tool (DST) that predicts optimal dosage based on repeated blood samples the f…
Phase: NA • Sponsor: University Hospital of North Norway • Aim: Symptom relief
Last updated Jun 26, 2026 16:45 UTC
-
Heart attack recovery: could Lower-Dose statins be just as good?
Disease control CompletedThis study evaluates the effectiveness of high- and moderate-intensity statins in achieving target low-density lipoprotein cholesterol (LDL-C) levels in patients with acute coronary syndrome (ACS). The study aims to determine whether moderate-intensity statins can provide compara…
Phase: NA • Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New bladder cancer drug shows promise in early trial
Disease control Recruiting nowThe goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having certain problems. Researchers will then choose a dose level of Sacituzumab Tirumotec…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Brain stimulation trial targets depression in autism
Symptom relief Recruiting nowDepression is a common complication of Autism Spectrum Disorder (ASD): it is four times more prevalent in people with ASD than in the general population. However, treating depression in people with ASD is complicated by the lack of guidelines. Antidepressants appear to be less e…
Phase: NA • Sponsor: Hospital Center Guillaume Régnier • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New lens aims to sharpen vision at all distances after cataract surgery
Disease control Recruiting nowThe study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.
Phase: NA • Sponsor: Cutting Edge SAS • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a stiffer prosthetic foot help you keep your balance?
Symptom relief Recruiting nowThe goal of this clinical trial is to identify prosthesis stiffness that optimizes balance control in individuals with below knee amputations. The main question this clinical trial will answer is: • Is there an optimal stiffness that improves balance control for specific ambulat…
Phase: NA • Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New hope for leukemia patients? early trial launches
Disease control Recruiting nowEvaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ICP-248 in combination with azacitidine in patients with acute myelogenous leukemia and Myelodysplastic Syndromes.
Phase: PHASE1 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New heart lead aims to improve pacing for slow heartbeat
Disease control CompletedThe purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia CSP S pacing lead when implanted in the left bundle branch area (LBBA). Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post…
Phase: NA • Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Your smartwatch might spot sleep apnea!
Diagnosis CompletedThe study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
Sponsor: Stanford University • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC